NCT01264094View on ClinicalTrials.gov

A Study to Evaluate the Efficacy and the Change of sAg Levels in Chronic Hepatitis B Patients Receiving Clevudine Treatment Over the Long Period

PHASE4TerminatedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

November 30, 2014

Study Completion Date

June 30, 2015

Conditions
Chronic Hepatitis B
Interventions
DRUG

Clevudine

clevudine 30 mg qd

Trial Locations (1)

Unknown

Gangnam Severance Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Bukwang Pharmaceutical

INDUSTRY